Bright Minds Biosciences Inc.
DRUGBright Minds Biosciences Inc. in brief
Bright Minds Biosciences Inc. is a listed company in the Biotechnology industry, based in Chicago, Illinois, USA. Its market value was $750 M on 1 August 2026, which makes it the 10,714th largest listed company in the world and the 2,244th largest in the USA on this site. Its shares trade under the symbol DRUG (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Bright Minds Biosciences Inc.
Additional information related us is available on SEDAR+ at www.sedarplus.ca and on our website at https://brightmindsbio.com/. We do not incorporate the contents of our website or of www.sedarplus.ca into this Annual Report. Information on our website does not constitute part of this Annual Report. In addition, the SEC maintains an internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC which can be viewed as www.sec.gov.
We are a biotechnology company dedicated to developing therapeutics to improve the lives of patients with severe and life-altering diseases, which was incorporated on May 31, 2019 under the laws of British Columbia, Canada.
From the company's annual report filed with the US SEC: read the report
Bright Minds Biosciences Inc. timeline
- 2020
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
Events of Bright Minds Biosciences Inc. from SEC EDGAR. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #5,472 (Dec 2022) · #5,293 (Jul 2023) · #4,557 (Jan 2024) · #1,011 (Mar 2026) · #2,275 (Aug 2026)
Key ratios
- P/E ratio
- n/m (loss)
- Price / sales
- —
- Price / book
- 182.9×
- Free cash flow yield
- —
- Net margin
- —
- Operating margin
- —
- Return on equity
- -50.2%
- Liabilities / assets
- 9.3%
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Sep 2024 | — | — | — | $-2M | — |
| Sep 2023 | — | — | — | $-5M | — |
| Sep 2022 | — | — | — | $-12M | — |
| Sep 2021 | — | — | — | $-7M | — |
| Sep 2020 | — | — | — | $-0M | — |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Sep 2024 | $-1M | — | — | $-0.48 | — |
| Sep 2023 | $-5M | — | — | $-1.47 | — |
| Sep 2022 | $-11M | — | — | $-4.74 | — |
| Sep 2021 | $-6M | — | — | $-3.81 | — |
| Sep 2020 | $-0M | — | — | $-0.10 | — |
SEC filings
- Nov 2, 20266-KReport of foreign issuer
- Oct 2, 20266-KReport of foreign issuer
- Oct 1, 20266-KReport of foreign issuer
- Aug 17, 20266-KReport of foreign issuer
- Jun 3, 20266-KReport of foreign issuer
- Jun 2, 20266-KReport of foreign issuer
- May 28, 20266-KReport of foreign issuer
- May 20, 20266-KReport of foreign issuer
- Feb 13, 20266-KReport of foreign issuer
- Jan 9, 20266-KReport of foreign issuer
- Jan 9, 20266-KReport of foreign issuer
- Jan 8, 20266-KReport of foreign issuer
Official filings of Bright Minds Biosciences Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- —
- Operating income
- —
- Net income
- $-2 M
For year ending September-2024 · source: SEC filing
Balance sheet
- Total assets
- $5 M
- Total liabilities
- $0 M
- Total equity
- $4 M
As of September-2024
Top 100 institutional investors in Bright Minds Biosciences Inc.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | Janus Henderson Group Ltd. | 1,349,107 | — | 13.18% | $67 M | Nov 16, 2026 |
| 2 | Cormorant Asset Management, LP | 800,000 | -100,000 (-11.11%) | 7.81% | $40 M | Nov 16, 2026 |
| 3 | BlackRock, Inc. | 651,794 | -34,390 (-5.01%) | 6.37% | $32 M | Nov 13, 2026 |
| 4 | Vestal Point Capital, LP | 545,000 | 0 (0.00%) | 5.32% | $27 M | Nov 16, 2026 |
| 5 | Braidwell LP | 483,822 | 0 (0.00%) | 4.73% | $24 M | Nov 16, 2026 |
| 6 | Driehaus Capital Management LLC | 445,221 | +11,844 (+2.73%) | 4.35% | $22 M | Nov 16, 2026 |
| 7 | Vivo Capital, LLC | 417,879 | -139,293 (-25.00%) | 4.08% | $21 M | Nov 13, 2026 |
| 8 | Point72 Asset Management, L.P. | 372,481 | +45,065 (+13.76%) | 3.64% | $19 M | Nov 16, 2026 |
| 9 | Adage Capital Partners GP, L.L.C. | 324,800 | -10,200 (-3.04%) | 3.17% | $16 M | Nov 16, 2026 |
| 10 | Balyasny Asset Management L.P. | 304,561 | -40,492 (-11.74%) | 2.98% | $15 M | Nov 16, 2026 |
| 11 | Ra Capital Management, L.P. | 265,000 | 0 (0.00%) | 2.59% | $13 M | Nov 16, 2026 |
| 12 | Deerfield Management Company, L.P. | 236,295 | -46,705 (-16.50%) | 2.31% | $12 M | Nov 16, 2026 |
| 13 | Wellington Management Group LLP | 221,361 | +50,046 (+29.21%) | 2.16% | $11 M | Nov 16, 2026 |
| 14 | MPM Bioimpact LLC | 195,669 | -6,445 (-3.19%) | 1.91% | $10 M | Nov 16, 2026 |
| 15 | Parkman Healthcare Partners LLC | 148,227 | -56,826 (-27.71%) | 1.45% | $7 M | Nov 16, 2026 |
| 16 | Goldman Sachs Group Inc | 135,089 | +1,400 (+1.05%) | 1.32% | $7 M | Nov 16, 2026 |
| 17 | Eventide Asset Management, LLC | 130,013 | 0 (0.00%) | 1.27% | $6 M | Nov 13, 2026 |
| 18 | State Street Corp | 122,150 | -28 (-0.02%) | 1.19% | $6 M | Nov 12, 2026 |
| 19 | Great Point Partners LLC | 109,603 | 0 (0.00%) | 1.07% | $5 M | Nov 16, 2026 |
| 20 | Geode Capital Management, LLC | 104,059 | -87 (-0.08%) | 1.02% | $5 M | Nov 6, 2026 |
| 21 | B Group, Inc. | 95,000 | +27,500 (+40.74%) | 0.93% | $5 M | Nov 16, 2026 |
| 22 | Acuta Capital Partners, LLC | 93,152 | +407 (+0.44%) | 0.91% | $5 M | Nov 16, 2026 |
| 23 | Ikarian Capital, LLC | 88,951 | 0 (0.00%) | 0.87% | $4 M | Nov 16, 2026 |
| 24 | Millennium Management LLC | 88,640 | +21,900 (+32.81%) | 0.87% | $4 M | Nov 16, 2026 |
| 25 | Morgan Stanley | 87,809 | +69,210 (+372.12%) | 0.86% | $4 M | Nov 13, 2026 |
Show all 100: investors 26 to 100
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 26 | Orbimed Advisors LLC | 81,000 | -12,000 (-12.90%) | 0.79% | $4 M | Nov 16, 2026 |
| 27 | Sio Capital Management, LLC | 75,152 | +1,200 (+1.62%) | 0.73% | $4 M | Nov 16, 2026 |
| 28 | Ameriprise Financial Inc | 57,840 | +19,938 (+52.60%) | 0.56% | $3 M | Nov 16, 2026 |
| 29 | FMR LLC | 56,476 | +48,625 (+619.35%) | 0.55% | $3 M | Nov 10, 2026 |
| 30 | Citadel Advisors LLC | 54,116 | -12,417 (-18.66%) | 0.53% | $3 M | Nov 16, 2026 |
| 31 | Vanguard Portfolio Management LLC | 49,395 | -30,665 (-38.30%) | 0.48% | $2 M | Nov 13, 2026 |
| 32 | Superstring Capital Management LP | 48,045 | +17,589 (+57.75%) | 0.47% | $2 M | Nov 16, 2026 |
| 33 | Woodline Partners LP | 45,668 | 0 (0.00%) | 0.45% | $2 M | Nov 16, 2026 |
| 34 | Trexquant Investment LP | 41,852 | -28,763 (-40.73%) | 0.41% | $2 M | Nov 16, 2026 |
| 35 | Schonfeld Strategic Advisors LLC | 41,710 | -24,567 (-37.07%) | 0.41% | $2 M | Nov 16, 2026 |
| 36 | AdvisorShares Investments LLC | 39,822 | +15,548 (+64.05%) | 0.39% | $2 M | Nov 9, 2026 |
| 37 | Northern Trust Corp | 39,796 | -2,670 (-6.29%) | 0.39% | $2 M | Nov 16, 2026 |
| 38 | Artia Global Partners LP | 38,407 | 0 (0.00%) | 0.38% | $2 M | Nov 16, 2026 |
| 39 | Los Angeles Capital Management LLC | 35,375 | -372 (-1.04%) | 0.35% | $2 M | Nov 12, 2026 |
| 40 | ADAR1 Capital Management, LLC | 32,300 | +2,000 (+6.60%) | 0.32% | $2 M | Nov 16, 2026 |
| 41 | KVP Capital Advisors, LP | 31,813 | 0 (0.00%) | 0.31% | $2 M | Nov 16, 2026 |
| 42 | Walleye Capital LLC | 28,729 | -37,377 (-56.54%) | 0.28% | $1 M | Nov 13, 2026 |
| 43 | Boothbay Fund Management, LLC | 21,979 | -5,891 (-21.14%) | 0.21% | $1 M | Nov 16, 2026 |
| 44 | D. E. Shaw & Co., Inc. | 20,790 | New | 0.20% | $1 M | Nov 16, 2026 |
| 45 | Quadrature Capital Ltd | 19,989 | New | 0.20% | $1 M | Nov 13, 2026 |
| 46 | Jane Street Group, LLC | 19,156 | +12,756 (+199.31%) | 0.19% | $1 M | Nov 12, 2026 |
| 47 | Platinum Investment Management LTD | 19,127 | 0 (0.00%) | 0.19% | $1 M | Nov 16, 2026 |
| 48 | HRT Financial LP | 19,019 | New | 0.19% | $1 M | Nov 13, 2026 |
| 49 | Charles Schwab Investment Management Inc | 17,190 | -842 (-4.67%) | 0.17% | $1 M | Nov 16, 2026 |
| 50 | Quantinno Capital Management LP | 16,300 | New | 0.16% | $1 M | Nov 13, 2026 |
| 51 | Nuveen, LLC | 16,192 | -697 (-4.13%) | 0.16% | $1 M | Nov 10, 2026 |
| 52 | Birchview Capital, LP | 15,400 | New | 0.15% | $1 M | Nov 13, 2026 |
| 53 | Exome Asset Management LLC | 14,715 | +4,605 (+45.55%) | 0.14% | $1 M | Nov 16, 2026 |
| 54 | Bank of New York Mellon Corp | 14,511 | -391 (-2.62%) | 0.14% | $1 M | Nov 5, 2026 |
| 55 | Bank Of America Corp /de/ | 13,942 | -13,024 (-48.30%) | 0.14% | $1 M | Nov 16, 2026 |
| 56 | Engineers Gate Manager LP | 11,140 | +5,728 (+105.84%) | 0.11% | $1 M | Nov 16, 2026 |
| 57 | Rhumbline Advisers | 9,001 | +268 (+3.07%) | 0.09% | $0 M | Nov 10, 2026 |
| 58 | Tudor Investment Corp Et Al | 8,241 | -50 (-0.60%) | 0.08% | $0 M | Nov 16, 2026 |
| 59 | DNB Asset Management As | 7,653 | +2,831 (+58.71%) | 0.07% | $0 M | Nov 12, 2026 |
| 60 | Jpmorgan Chase & Co | 7,487 | +2,709 (+56.70%) | 0.07% | $0 M | Nov 12, 2026 |
| 61 | UBS Group AG | 7,286 | -8,250 (-53.10%) | 0.07% | $0 M | Nov 10, 2026 |
| 62 | Deutsche Bank AG\ | 6,973 | -835 (-10.69%) | 0.07% | $0 M | Nov 6, 2026 |
| 63 | Public Employees Retirement System Of Ohio | 6,930 | New | 0.07% | $0 M | Nov 16, 2026 |
| 64 | LPL Financial LLC | 6,895 | 0 (0.00%) | 0.07% | $0 M | Nov 6, 2026 |
| 65 | American Century Companies Inc | 6,593 | New | 0.06% | $0 M | Nov 12, 2026 |
| 66 | Vanguard Fiduciary Trust Co | 6,504 | -497 (-7.10%) | 0.06% | $0 M | Nov 13, 2026 |
| 67 | Seven Fleet Capital Management LP | 6,395 | 0 (0.00%) | 0.06% | $0 M | Nov 16, 2026 |
| 68 | Price T Rowe Associates Inc /MD/ | 6,167 | 0 (0.00%) | 0.06% | $0 M | Nov 16, 2026 |
| 69 | State Board Of Administration Of Florida Retirement System | 6,091 | 0 (0.00%) | 0.06% | $0 M | Nov 13, 2026 |
| 70 | ExodusPoint Capital Management, LP | 5,488 | New | 0.05% | $0 M | Nov 16, 2026 |
| 71 | Aquatic Capital Management LLC | 4,950 | -15,881 (-76.24%) | 0.05% | $0 M | Nov 16, 2026 |
| 72 | Alliancebernstein L.P. | 4,810 | -870 (-15.32%) | 0.05% | $0 M | Nov 16, 2026 |
| 73 | MetLife Investment Management, LLC | 4,511 | 0 (0.00%) | 0.04% | $0 M | Nov 16, 2026 |
| 74 | MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 3,392 | -20 (-0.59%) | 0.03% | $0 M | Nov 16, 2026 |
| 75 | Tower Research Capital LLC (TRC) | 3,091 | +2,080 (+205.74%) | 0.03% | $0 M | Nov 16, 2026 |
| 76 | Barclays PLC | 2,940 | -316 (-9.71%) | 0.03% | $0 M | Nov 6, 2026 |
| 77 | New York State Common Retirement Fund | 2,600 | 0 (0.00%) | 0.03% | $0 M | Nov 17, 2026 |
| 78 | Wells Fargo & Company/mn | 2,150 | -4,611 (-68.20%) | 0.02% | $0 M | Nov 16, 2026 |
| 79 | Russell Investments Group, Ltd. | 2,144 | -409 (-16.02%) | 0.02% | $0 M | Nov 6, 2026 |
| 80 | Police & Firemen's Retirement System of New Jersey | 2,036 | 0 (0.00%) | 0.02% | $0 M | Nov 9, 2026 |
| 81 | BNP Paribas Financial Markets | 1,839 | +605 (+49.03%) | 0.02% | $0 M | Nov 12, 2026 |
| 82 | Natixis | 1,791 | New | 0.02% | $0 M | Nov 6, 2026 |
| 83 | Royal Bank Of Canada | 1,473 | +340 (+30.01%) | 0.01% | $0 M | Nov 16, 2026 |
| 84 | Strs Ohio | 900 | -2,400 (-72.73%) | 0.01% | $0 M | Oct 30, 2026 |
| 85 | Legal & General Group Plc | 718 | 0 (0.00%) | 0.01% | $0 M | Nov 16, 2026 |
| 86 | Ameritas Investment Partners, Inc. | 672 | 0 (0.00%) | 0.01% | $0 M | Nov 13, 2026 |
| 87 | China Universal Asset Management Co., Ltd. | 500 | -100 (-16.67%) | 0.00% | $0 M | Oct 28, 2026 |
| 88 | Citigroup Inc | 429 | -3,183 (-88.12%) | 0.00% | $0 M | Nov 4, 2026 |
| 89 | Osaic Holdings, Inc. | 294 | +214 (+267.50%) | 0.00% | $0 M | Nov 12, 2026 |
| 90 | Sterling Capital Management LLC | 243 | +217 (+834.62%) | 0.00% | $0 M | Oct 22, 2026 |
| 91 | Allworth Financial LP | 155 | +107 (+222.92%) | 0.00% | $0 M | Nov 17, 2026 |
| 92 | Arax Advisory Partners | 100 | +89 (+809.09%) | 0.00% | $0 M | Nov 12, 2026 |
| 93 | California State Teachers Retirement System | 98 | 0 (0.00%) | 0.00% | $0 M | Nov 13, 2026 |
| 94 | Rydar Equities, Inc. | 80 | New | 0.00% | $0 M | Oct 13, 2026 |
| 95 | Farther Finance Advisors, LLC | 47 | New | 0.00% | $0 M | Oct 8, 2026 |
| 96 | GAMMA Investing LLC | 46 | +26 (+130.00%) | 0.00% | $0 M | Oct 8, 2026 |
| 97 | Vanguard Global Advisers, LLC | 32 | -3,838 (-99.17%) | 0.00% | $0 M | Nov 13, 2026 |
| 98 | Pinnacle Wealth Planning Services, Inc. | 27 | -111 (-80.43%) | 0.00% | $0 M | Oct 27, 2026 |
| 99 | Caitong International Asset Management Co., Ltd | 21 | -1,180 (-98.25%) | 0.00% | $0 M | Oct 29, 2026 |
| 100 | TD Waterhouse Canada Inc. | 20 | 0 (0.00%) | 0.00% | $0 M | Oct 16, 2026 |
Mutual funds holding Bright Minds Biosciences Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors | 194,417 | $14 M | 1.9% | 0.02% | +15% | Jun 30, 2026 |
| 🇺🇸 Eventide Healthcare & Life Sciences FundEventide Asset Management, LLC | 130,013 | $9 M | 1.3% | 0.51% | no change | Jun 30, 2026 |
| 🇺🇸 BlackRock Health Sciences Opportunities PortfolioBlackRock Advisors, LLC | 95,655 | $8 M | 0.93% | 0.14% | no change | May 29, 2026 |
| 🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC | 81,231 | $6 M | 0.79% | 0.02% | +18% | Jul 31, 2026 |
| 🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors | 69,591 | $5 M | 0.68% | 0.03% | +22% | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc. | 35,879 | $3 M | 0.35% | 0.02% | +43% | May 31, 2026 |
| 🇺🇸 Driehaus Micro Cap Growth FundDriehaus Capital Management LLC | 41,568 | $3 M | 0.41% | 0.49% | −1.0% | Jun 30, 2026 |
| 🇺🇸 Vanguard U.S. Momentum Factor ETFThe Vanguard Group, Inc. | 28,882 | $3 M | 0.28% | 0.14% | +30% | May 31, 2026 |
| 🇺🇸 BlackRock Health Sciences Term TrustBlackRock Advisors, LLC | 31,933 | $2 M | 0.31% | 0.21% | no change | Jun 30, 2026 |
| 🇺🇸 Adara Smaller Companies FundRBB Fund, Inc. | 20,238 | $2 M | 0.20% | 0.22% | no change | May 31, 2026 |
| 🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors | 24,919 | $2 M | 0.24% | 0.12% | +42% | Jun 30, 2026 |
| 🇺🇸 Blackstone Alternative Multi-Strategy FundBlackstone Alternative Investment Advisors LLC | 22,267 | $2 M | 0.22% | 0.04% | +31% | Jun 30, 2026 |
| 🇺🇸 Goldman Sachs Small Cap Equity Insights FundGoldman Sachs Asset Management, L.P. | 18,815 | $1 M | 0.18% | 0.14% | +328% | Jul 31, 2026 |
| 🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc. | 18,032 | $1 M | 0.18% | 0.02% | +18% | Jul 31, 2026 |
| 🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC | 13,852 | $1 M | 0.14% | 0.02% | +22% | Jun 30, 2026 |
| 🇺🇸 Goldman Sachs Small Cap Growth Insights FundGoldman Sachs Asset Management, L.P. | 11,730 | $1 M | 0.11% | 0.26% | +220% | Jul 31, 2026 |
| 🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC | 9,859 | $1 M | 0.10% | 0.02% | +18% | Jul 31, 2026 |
| 🇺🇸 Destinations Small-Mid Cap Equity FundBrinker Capital Investments, LLC | 7,015 | $1 M | 0.07% | 0.08% | −7.8% | May 31, 2026 |
| 🇺🇸 BlackRock Health Sciences TrustBlackRock Advisors, LLC | 8,368 | $1 M | 0.08% | 0.10% | no change | Jun 30, 2026 |
| 🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC | 8,241 | $1 M | 0.08% | 0.02% | +14% | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc. | 6,507 | $1 M | 0.06% | 0.03% | +41% | May 31, 2026 |
| 🇺🇸 LVIP Franklin Templeton Multi-Factor SMID Cap Equity FundLincoln Financial Investments Corporation | 8,020 | $1 M | 0.08% | 0.05% | new | Jun 30, 2026 |
| 🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC | 6,137 | $1 M | 0.06% | <0.01% | +15% | May 31, 2026 |
| 🇺🇸 State Street SPDR S&P International Small Cap ETFSSGA Funds Management, Inc. | 7,531 | $1 M | 0.07% | 0.06% | +1.1% | Jun 30, 2026 |
| 🇺🇸 Fidelity Enhanced Small Cap Core ETFFidelity Management & Research Company LLC | 7,054 | $0 M | 0.07% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC | 6,943 | $0 M | 0.07% | 0.03% | +31% | Jun 30, 2026 |
| 🇺🇸 Health Sciences PortfolioPacific Life Fund Advisors LLC | 5,663 | $0 M | 0.06% | 0.10% | no change | Jun 30, 2026 |
| 🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation | 5,400 | $0 M | 0.05% | 0.02% | +54% | Jun 30, 2026 |
| 🇺🇸 SIMT Small Cap FundSEI Institutional Managed Trust | 5,400 | $0 M | 0.05% | 0.07% | new | Jun 30, 2026 |
| 🇺🇸 Nuveen Equity Index FundTeachers Advisors, LLC | 5,025 | $0 M | 0.05% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC | 4,810 | $0 M | 0.05% | 0.02% | +2432% | Jun 30, 2026 |
| 🇺🇸 Goldman Sachs Variable Insurance Trust Small Cap Equity Insights FundGoldman Sachs Asset Management, L.P. | 4,402 | $0 M | 0.04% | 0.13% | new | Jun 30, 2026 |
| 🇺🇸 NVIT GS Small Cap Equity Insights FundNATIONWIDE FUND ADVISORS | 4,059 | $0 M | 0.04% | 0.13% | +115% | Jun 30, 2026 |
| 🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc. | 3,805 | $0 M | 0.04% | 0.02% | +16% | Jun 30, 2026 |
| 🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC | 3,553 | $0 M | 0.03% | 0.02% | +17% | Jul 31, 2026 |
| 🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company | 2,886 | $0 M | 0.03% | 0.02% | +36% | May 31, 2026 |
| 🇺🇸 Goldman Sachs ActiveBeta U.S. Small Cap Equity ETFGoldman Sachs Asset Management, L.P. | 2,740 | $0 M | 0.03% | 0.02% | new | May 31, 2026 |
| 🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC | 2,528 | $0 M | 0.02% | 0.02% | +18% | Jun 30, 2026 |
| 🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc. | 2,400 | $0 M | 0.02% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC | 2,270 | $0 M | 0.02% | 0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC | 2,235 | $0 M | 0.02% | 0.02% | +23% | Jun 30, 2026 |
| 🇺🇸 iShares Russell 3000 ETFBlackRock Fund Advisors | 1,977 | $0 M | 0.02% | <0.01% | −0.7% | Jun 30, 2026 |
| 🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION | 1,500 | $0 M | 0.01% | 0.01% | +150% | May 31, 2026 |
| 🇺🇸 Multi-Manager U.S. Small Cap Equity FundGoldman Sachs Asset Management, L.P. | 1,466 | $0 M | 0.01% | 0.04% | — | Apr 30, 2026 |
| 🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC | 1,663 | $0 M | 0.02% | 0.05% | +33% | Jun 30, 2026 |
| 🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS | 1,651 | $0 M | 0.02% | 0.02% | +21% | Jun 30, 2026 |
| 🇺🇸 Small Cap Index TrustJohn Hancock Variable Trust Advisers LLC | 1,516 | $0 M | 0.01% | 0.02% | +19% | Jun 30, 2026 |
| 🇺🇸 AQR Small Cap Momentum Style FundAQR CAPITAL MANAGEMENT, LLC | 1,419 | $0 M | 0.01% | 0.06% | — | Mar 31, 2026 |
| 🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC | 1,315 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC | 1,196 | $0 M | 0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc. | 1,163 | $0 M | 0.01% | 0.02% | +19% | Jun 30, 2026 |
| 🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc. | 1,131 | $0 M | 0.01% | 0.02% | +42% | Jun 30, 2026 |
| 🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 1,121 | $0 M | 0.01% | 0.02% | +19% | Jun 30, 2026 |
| 🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC | 1,043 | $0 M | 0.01% | 0.02% | +23% | Jun 30, 2026 |
| 🇺🇸 Voya RussellTM Small Cap Index PortfolioVoya Investments, LLC | 911 | $0 M | <0.01% | 0.02% | +29% | Jun 30, 2026 |
| 🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC | 868 | $0 M | <0.01% | 0.02% | +69% | Jul 31, 2026 |
| 🇺🇸 Vanguard Russell 3000 Index FundThe Vanguard Group, Inc. | 587 | $0 M | <0.01% | <0.01% | +67% | May 31, 2026 |
| 🇺🇸 Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS | 677 | $0 M | <0.01% | 0.02% | +23% | Jul 31, 2026 |
| 🇺🇸 PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC | 675 | $0 M | <0.01% | 0.03% | +30% | Jun 30, 2026 |
| 🇺🇸 CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management | 672 | $0 M | <0.01% | 0.02% | +43% | Jun 30, 2026 |
| 🇺🇸 SmallCap Growth Fund IPrincipal Global Investors, LLC | 639 | $0 M | <0.01% | <0.01% | +56% | Jul 31, 2026 |
| 🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC | 588 | $0 M | <0.01% | 0.02% | +54% | Jun 30, 2026 |
| 🇺🇸 Voya VACS Index Series SC PortfolioVoya Investments, LLC | 499 | $0 M | <0.01% | 0.02% | +21% | Jun 30, 2026 |
| 🇺🇸 iShares Total U.S. Stock Market Index FundBlackRock Advisors, LLC | 462 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 ProShares Russell 2000 High Income ETFPROSHARE ADVISORS LLC | 328 | $0 M | <0.01% | 0.02% | +50% | May 31, 2026 |
| 🇺🇸 Strategic Equity Allocation TrustJohn Hancock Variable Trust Advisers LLC | 329 | $0 M | <0.01% | <0.01% | −33% | Jun 30, 2026 |
| 🇺🇸 ProShares UltraPro Russell2000PROSHARE ADVISORS LLC | 261 | $0 M | <0.01% | <0.01% | −16% | May 31, 2026 |
| 🇺🇸 ProShares Ultra Russell2000PROSHARE ADVISORS LLC | 257 | $0 M | <0.01% | <0.01% | −18% | May 31, 2026 |
| 🇺🇸 EQ/Franklin Small Cap Value Managed Volatility PortfolioEquitable Investment Management Group, LLC | 229 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Morgan Stanley Pathway Small-Mid Cap Equity ETFCONSULTING GROUP ADVISORY SERVICES LLC | 136 | $0 M | <0.01% | <0.01% | −9.3% | May 31, 2026 |
| 🇺🇸 State Street Total Return V.I.S. FundSSGA Funds Management, Inc. | 169 | $0 M | <0.01% | <0.01% | +1.8% | Jun 30, 2026 |
| 🇺🇸 Nationwide Fundamental All Cap Equity PortfolioNATIONWIDE FUND ADVISORS | 150 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Total Stock Market Index TrustJohn Hancock Variable Trust Advisers LLC | 155 | $0 M | <0.01% | <0.01% | +30% | Jun 30, 2026 |
| 🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P. | 39 | $0 M | <0.01% | <0.01% | +56% | Jun 30, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 74 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at Bright Minds Biosciences Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Cormorant Asset Management, LPFormer 10% Owner | Sellindirect | -109,331 | 89.50 | 9.8 Mlocal | 950,000 | Form 4 |
| filed | Cormorant Asset Management, LP10% owner | Buyindirect | +184,331 | 21.70 | 4.0 Mlocal | 1.06 M | Form 4 |
| filed | Cormorant Global Healthcare Master Fund, LP10% owner | Buyindirect | +39,743 | 23.22 | 923 Klocal | 864,743 | Form 4 |
| filed | Cormorant Global Healthcare Master Fund, LP10% owner | Buyindirect | +7,150 | 24.03 | 172 Klocal | 871,893 | Form 4 |
| filed | Cormorant Global Healthcare Master Fund, LP10% owner | Buyindirect | +3,107 | 25.22 | 78 Klocal | 875,000 | Form 4 |
| filed | Cormorant Global Healthcare Master Fund, LP10% owner | Buyindirect | +238,097 | 4.530 | 1.1 Mlocal | 690,506 | Form 4 |
| filed | Cormorant Global Healthcare Master Fund, LP10% owner | Buyindirect | +63,173 | 5.920 | 374 Klocal | 753,679 | Form 4 |
| filed | Cormorant Global Healthcare Master Fund, LP10% owner | Buyindirect | +33,343 | 6.420 | 214 Klocal | 787,022 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals. This company files with the SEC as a foreign issuer; its insiders often report prices in the home currency, so amounts are as filed and not converted to dollars
Markets and events: Bright Minds Biosciences Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Trading halts
- 2026-11-02 12:25 UTC, code T3, resumed 13:00 UTC
Fails to deliver
- : 280 shares at $56.69
- : 850 shares at $54.02
- : 78 shares at $50.44
- : 297 shares at $50.71
- : 2,775 shares at $51.36
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
Bright Minds Biosciences Inc. scorecard#
Passes 1 of the 7 checks that could be worked out. Fiscal year 2024; market cap of Aug 1, 2026.
Valuationnot known
- –P/E below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
- –Price to book below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
- –Price to sales below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
- –Free cash flow yield above 5%The market cap dates from 2026-08-01, more than 60 days ago.
- –Earnings yield above the 10-year Treasury yieldThe market cap dates from 2026-08-01, more than 60 days ago.
- –The price assumes slower growth than the last three years'The market cap dates from 2026-08-01, more than 60 days ago.
Growth0 of 1
- –Revenue grew in the newest yearRevenue of the year before is not on file.
- –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
- –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
- ✗Earnings per share grew in the newest year-0.48 vs -1.47Diluted EPS -0.48 in fiscal 2024 against -1.47 the year before (report's currency).
- –Net income higher than five years earlierNet income of five years earlier is not on file.
- –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
Profitability0 of 3
- ✗Profitable in the newest year-$2 MNet income -$2 M in fiscal 2024.
- ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2024.
- –Operating margin above its peers' medianNo operating margin on file.
- ✗Return on equity above 15%-45.7%-45.7% in fiscal 2024.
- –Return on invested capital above 10%No return on invested capital on file.
- –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
Financial health1 of 2
- ✓Short-term assets cover short-term liabilities11.4×Current ratio 11.36 at the end of fiscal 2024.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- –Operating income covers interest five timesInterest expense is not on file.
- ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2024.
- –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
Shareholder returns0 of 1
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✗Share count up no more than 2% in a year15.9%Diluted shares up 15.9% in fiscal 2024.
- –Dividends and buybacks above 3% of the market valueThe market cap dates from 2026-08-01, more than 60 days ago.
- –Free cash flow covers dividends and buybacksCash from operations or capital spending is not on file.
Worked out from the statements as filed (sec), the medians of Biotechnology, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Bright Minds Biosciences Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in CAD thousands; per-share figures in CAD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2024to Sep 30, 2024 | FY 2023to Sep 30, 2023 | FY 2022to Sep 30, 2022 | FY 2021to Sep 30, 2021 | FY 2020to Sep 30, 2020 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Research and development | 1,180−76.4%— | 5,000−59.0%— | 12,181+92.9%— | 6,314+1679%— | 355—— | |
| Selling and marketing | 42−65.2%— | 119−78.4%— | 552−35.2%— | 852+8760%— | 9.6—— | |
| Interest and finance income | 30—— | 0—— | 0—— | — | — | |
| Income tax | 0—— | 0—— | 0—— | 0—— | 0—— | |
| Net income including minority interests | −2,802—— | −7,372—— | −14,965—— | −8,651—— | −480—— | |
| Earnings per share, basic | -0.65—— | -1.98—— | -6.06—— | -4.82—— | — | |
| Earnings per share, diluted | -0.65—— | -1.98—— | -6.06r-1.21—— | -4.82r-0.96—— | -0.13—— | |
| Shares, weighted average (basic) | 4.3+15.9%— | 3.7+50.6%— | 2.5r12+37.6%— | 1.8r9.0−50.3%— | 3.6—— | |
| Shares, weighted average (diluted) | 4.3+15.9%— | 3.7+50.6%— | 2.5+37.6%— | 1.8—— | — | |
| Balance sheet | ||||||
| Cash and cash equivalents | 5,720−15.2%93.7% | 6,748−42.0%98.1% | 11,628−41.2%96.2% | 19,760+2370%98.6% | 800—90.9% | |
| Current assets | 5,987−12.1%98.1% | 6,813−43.0%99.0% | 11,948−40.4%98.9% | 20,038+2182%100.0% | 878—99.8% | |
| Right-of-use (leased) assets | 118+77.2%1.9% | 66−52.2%1.0% | 139—1.1% | 0—0.0% | — | |
| Total assets | 6,105−11.3%100% | 6,879−43.1%100% | 12,087−39.7%100% | 20,040+2177%100% | 880—100% | |
| Accounts payable | 449+117%7.4% | 207−85.2%3.0% | 1,405+120%11.6% | 639+323%3.2% | 151—17.1% | |
| Current liabilities | 529+88.2%8.7% | 281−80.9%4.1% | 1,472+131%12.2% | 639—3.2% | — | |
| Lease liabilities (non-current) | 40—0.6% | 0−100%0.0% | 72—0.6% | 0—0.0% | — | |
| Total liabilities | 568+102%9.3% | 281−81.8%4.1% | 1,544+142%12.8% | 639+323%3.2% | 151—17.1% | |
| Retained earnings | −34,349—−563% | −31,547—−459% | −24,175—−200% | −9,210—−46.0% | −559—−63.5% | |
| Total equity | 5,536−16.1%90.7% | 6,598−37.4%95.9% | 10,543−45.7%87.2% | 19,402+2560%96.8% | 729—82.9% | |
| Total liabilities and equity | 6,105−11.3%100% | 6,879−43.1%100% | 12,087−39.7%100% | 20,040+2177%100% | 880—100% | |
| Cash-flow statement | ||||||
| Depreciation and amortization | 73+1.3%— | 72+1100%— | 6.0—— | 0—— | 0—— | |
| Share-based compensation | 840−27.1%— | 1,152+31.7%— | 875−0.6%— | 881+446%— | 161—— | |
| Cash from operating activities | −1,850—— | −7,024—— | −13,587—— | −7,319—— | −288—— | |
| Shares issued | — | — | — | 27,745+2652%— | 1,008—— | |
| Cash from financing activities | 811−63.0%— | 2,190−57.9%— | 5,196−80.1%— | 26,056+2484%— | 1,008—— | |
| Exchange-rate effect on cash | 12—— | −45−118%— | 259+15.7%— | 224—— | 0—— | |
| Change in cash | −1,040—— | −4,835—— | −8,391−145%— | 18,736+2502%— | 720—— | |
| Report | 20-F | 20-F | 20-F | 20-F | 20-F | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2024. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
Acquisitions and funding#
Private share sales · funding history
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Nov 2024 | $35 M | Private placement after listing | $10 to $50 million | 13 | equity | SEC |
Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.
H-1B hiring at Bright Minds Biosciences Inc.#
1 labor condition applications certified in fiscal 2026 for 1 positions, at a median wage of $207 K a year.
| Job title | Positions | Median wage offered |
|---|---|---|
| Chief Operations OfficerNatural Sciences Managers | 1 | $207 K |
Where: Chicago, IL 1
| Fiscal year | Certified | Positions | Median wage | Filed |
|---|---|---|---|---|
| FY2026 | 1 | 1 | $207 K | 1 |
| FY2024 | 1 | 1 | $72 K | 1 |
| FY2021 | 1 | 1 | $64 K | 1 |
Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Bright Minds Biosciences LLC and Bright Minds Biosciences LLC
Discuss Bright Minds Biosciences Inc.#
1 automatic updates and 0 member comments. Sign in to comment and react.
- Mutual funds: 74 funds hold $74 millionautomatic update · Jul 31, 2026
74 mutual funds in 1 country hold shares of Bright Minds Biosciences Inc. worth $74 million, about 9.8% of the company (funds' newest reports, up to 31 July 2026). Since their previous reports 52 funds added shares and 9 sold; on balance they bought $12 million. Share splits are not counted as trading.
How Bright Minds Biosciences Inc. compares in Biotechnology
- Market cap$750 M · higher than 63% of 726
- Price / book182.9× · lower than 1% of 534
- 🇨🇳 Guizhou Sanli Pharmaceutical Co., Ltd$747 M
- 🇺🇸 Sagimet Biosciences Inc.$744 M
- 🇨🇦 Cybin D/B/A Helus Pharma$743 M
- 🇫🇷 Valneva SE$759 M
- 🇨🇳 Alphamab Oncology$767 M
- 🇺🇸 Apnimed, Inc.$722 M
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Bright Minds Biosciences Inc.🇺🇸 | $750 M | — | — | — |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Guizhou Sanli Pharmaceutical Co., Ltd$747 M
- Sagimet Biosciences Inc.$744 M
- Cybin D/B/A Helus Pharma$743 M
- Valneva SE$759 M
- Alphamab Oncology$767 M
- Apnimed, Inc.$722 M
Sources and freshness
- Market cap:
- Aug 1, 2026
- Annual results:
- For year ending September-2024
- Balance sheet:
- As of September-2024
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research, SEC annual report; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Bright Minds Biosciences Inc.? Verify and update this profile — free
Show Bright Minds Biosciences Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.